NANOBIOTIX: Goldman Sachs reaches new thresholds

The Goldman Sachs Group, Inc. has crossed the 5% ownership threshold in Nanobiotix. This declaration, received on August 27, 2026, indicates that the group indirectly holds 2,855,579 shares, representing 5.60% of the share capital and 5.24% of the voting rights. This acquisition resulted from an off-market share purchase, with Goldman Sachs International as the principal individual shareholder.

The Goldman Sachs Group specified that it holds 23,411 shares through controlled companies, acquired via a securities lending agreement with a right to recall. It also holds 1,421,970 shares through 17 swap contracts. These derivative instruments are exercisable until 2036.